Search Within

Heiko Schoder

  1. "2020"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (9)
  3. Editorial (3)
  4. Review (3)
  5. Research Letter (1)
Groups
  1. Molecular Imaging and Therapy Service (30)
  2. Radiology, Department of (30)
  3. Department of Medicine (16)
  4. Sloan Kettering Institute Postdocs (16)
  5. Survivorship Research (12)
  6. Center for Hematologic Malignancies (10)

More Groups

People
  1. John Humm (6)
  2. Reiko Nakajima (6)
  3. Ahmet Dogan (5)
  4. Audrey Mauguen (5)
  5. Laure Michaud (5)
  6. Paul Hamlin (5)

More People

Years
  1. 2020 (30)
Publications
  1. Journal of Nuclear Medicine (6)
  2. Blood (4)
  3. Clinical Cancer Research (2)
  4. European Journal of Nuclear Medicine and Molecular Imaging (2)
  5. Leukemia and Lymphoma (2)
  6. Radiotherapy and Oncology (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (6)
  2. American Society of Hematology (5)
  3. Elsevier Inc. (4)
  4. Springer (3)
  5. American Association for Cancer Research (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local review versus (vs) central review of fluorodeoxyglucose positron emission tomography (FDG-PET) in diffuse large B-cell lymphoma (DLBCL): Results from the CALGB 50303 trial [alliance]
    Meeting Abstract

    Ruppert, A. S.; Pederson, L. D.; Knopp, M. V.; Poon, D.; Zhang, J.; Kahl, B. S.; Friedberg, J. W.; Schwartz, L. H.; Wilson, W. H.; Leonard, J. P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Frontline sequential immunochemotherapy plus lenalidomide for mantle cell lymphoma incorporating MRD evaluation: Phase II, investigator-initiated, single-center study
    Meeting Abstract

    Epstein-Peterson, Z. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Ho, C.; Jacob, A. P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Non-invasive radiomic imaging prediction of tumour hypoxia: Biomarker for FLASH irradiation?
    Meeting Abstract

    Sanduleanu, S.; Tamanupadhaya, T.; Klaassen, R.; Woodruff, H.; Hatt, M.; Kaanders, J.; Vrieze, O.; Laarhoven, H.; Subramiam, R.; Huang, S. H.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: A systematic review and meta-analysis
    Review

    Woo, S.; Ghafoor, S.; Becker, A. S.; Han, S.; Wibmer, A. G.; Hricak, H.; Burger, I. A.; Schòˆder, H.; Vargas, H. A.
    European Journal of Hybrid Imaging (2020)

    Fulltext@MSK | Save
  • End of therapy (18)F-FDG PET/CT for assessment of persistent bone involvement in B-cell lymphoma
    Meeting Abstract

    Michaud, L.; Nakajima, R.; Joffe, E.; Ghione, P.; Ahsanuddin, S.; Navitski, A.; Schoder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Ho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Perales, M. A.; Dahi, P. B.; Giralt, S. A.; Scordo, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures
    Journal Article

    Sanduleanu, S.; Jochems, A.; Upadhaya, T.; Even, A. J. G.; Leijenaar, R. T. H.; Dankers, F. J. W. M.; Klaassen, R.; Woodruff, H. C.; Hatt, M.; Kaanders, H. J. A. M.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • The future of nuclear medicine, molecular imaging, and theranostics
    Editorial

    Weber, W. A.; Czernin, J.; Anderson, C. J.; Badawi, R. D.; Barthel, H.; Bengel, F.; Bodei, L.; Buvat, I.; DiCarli, M.; Graham, M. M.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save